Pfizer’s Paxlovid Antiviral to Undergo Trial as Long Covid Medicament

2022-10-28 3,446

A trial is set to begin on January 1st to investigate a prime cause and cure for long Covid. Veuer’s Chloe Hurst has the story!

Videos similaires

Hope for long Covid sufferers as new study will trial Pfizer's antiviral Paxlovid in patients - 1br

New COVID pill: EMA gives Pfizer's antiviral drug Paxlovid the green light to be used in the EU

Pfizer's Q2 Revenue and Earnings Beat Expectations, as Sales of Pfizer's COVID Antiviral Pill Surpass Estimates

First batch of imported Pfizer's Paxlovid Covid-19 pills arrives in Shanghai

Covid-19: Paxlovid antiviral to be free, enough supply to treat 48,000 patients

Pfizer busca la aprobación de la FDA de su medicamento antiviral oral Covid-19, #Paxlovid.

España recibe las 11.000 primeras dosis de Paxlovid, el antiviral que reduce el 90% las hospitalizaciones por COVID-19

Pfizer busca la aprobación de la FDA de su medicamento antiviral oral Covid, Paxlovid

EUA ng antiviral Covid pill na Paxlovid, aprubado na ng FDA | SONA

Covid-19 : les autorités de santé autorisent le traitement antiviral Paxlovid

Web Analytics